MedTrace Logo

Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency

NCT03495635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1361

Last updated 2026-01-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of the Big Brothers Big Sisters of America (BBBSA) community-based mentoring (CBM) program for prevention of crime and delinquency/conduct problems, including risk and protective factors for these outcomes. Approximately 2,500 youth ages 10-16 will be randomly assigned to either the CBM program or an untreated control group. Study outcomes will be assessed over a 4-year period via both youth- and parent-report surveys and official records of police/court contact (e.g., arrests).

Conditions

  • Crime
  • Juvenile Delinquency

Interventions

BEHAVIORAL

Big Brothers Big Sisters Community-Based Mentoring Program

One-to-one mentoring provided by an adult volunteer with training and ongoing monitoring and support from program staff.

Sponsors & Collaborators

  • Laura and John Arnold Foundation

    collaborator OTHER

  • Herrera Consulting Group, LLC

    collaborator UNKNOWN

  • Big Brothers Big Sisters of America

    collaborator UNKNOWN

  • National Council of Juvenile and Family Court Judges

    collaborator UNKNOWN

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • David L DuBois, PhD · University of Illinois at Chicago

  • Carla Herrera, PhD · Herrera Consulting Group, LLC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-02
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03495635 on ClinicalTrials.gov